• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Comorbid Psoriasis and Metabolic Syndrome: Clinical Implications and Optimal Management.银屑病与代谢综合征共病:临床意义及最佳管理
Psoriasis (Auckl). 2022 May 25;12:113-126. doi: 10.2147/PTT.S293107. eCollection 2022.
2
[Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities].[银屑病患者合并症的综合治疗方法。银屑病相关合并症工作组]
Actas Dermosifiliogr. 2012 Jan;103 Suppl 1:1-64. doi: 10.1016/S0001-7310(12)70001-7.
3
Position statement for the management of comorbidities in psoriasis.银屑病合并症管理的立场声明。
J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2058-2073. doi: 10.1111/jdv.15177. Epub 2018 Aug 14.
4
Psoriasis and metabolic and cardiovascular comorbidities in children: A systematic review.儿童银屑病与代谢及心血管合并症:一项系统综述。
Arch Pediatr. 2019 Feb;26(2):86-94. doi: 10.1016/j.arcped.2018.12.005. Epub 2019 Jan 11.
5
Comorbidities associated with psoriatic arthritis: Review and update.与银屑病关节炎相关的共病:综述与更新。
Clin Immunol. 2020 May;214:108397. doi: 10.1016/j.clim.2020.108397. Epub 2020 Mar 27.
6
Comorbidities in Psoriatic Arthritis.银屑病关节炎的合并症
Rheum Dis Clin North Am. 2015 Nov;41(4):677-98. doi: 10.1016/j.rdc.2015.07.008. Epub 2015 Sep 5.
7
[Psoriasis comorbidities].[银屑病共病]
Cas Lek Cesk. 2017 Summer;156(3):119-122.
8
Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.代谢综合征、非酒精性脂肪性肝病与银屑病关节炎及银屑病患者的肝硬度。
Clin Rheumatol. 2019 Oct;38(10):2843-2850. doi: 10.1007/s10067-019-04646-7. Epub 2019 Jun 28.
9
Management of Psoriatic Arthritis in Patients With Comorbidities: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations.伴发疾病的银屑病关节炎患者的管理:更新文献综述以提供 2021 年 GRAPPA 治疗推荐意见。
J Rheumatol. 2023 Mar;50(3):426-432. doi: 10.3899/jrheum.220310. Epub 2022 Nov 1.
10
Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative.类风湿关节炎、银屑病和银屑病关节炎合并症管理的循证推荐:加拿大皮肤病学-风湿病学合并症倡议专家意见
J Rheumatol. 2015 Oct;42(10):1767-80. doi: 10.3899/jrheum.141112. Epub 2015 Jul 15.

引用本文的文献

1
Suppressive effect of topical moxifloxacin on imiquimod-induced model of psoriasis in mice.局部用莫西沙星对咪喹莫特诱导的小鼠银屑病模型的抑制作用。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun 3. doi: 10.1007/s00210-025-04317-2.
2
Apremilast as a Potential Targeted Therapy for Metabolic Syndrome in Patients with Psoriasis: An Observational Analysis.阿普司特作为银屑病患者代谢综合征的潜在靶向治疗:一项观察性分析。
Pharmaceuticals (Basel). 2024 Jul 26;17(8):989. doi: 10.3390/ph17080989.
3
Patient perspective on psoriasis: Psychosocial burden of psoriasis and its management in Malaysia.患者对银屑病的看法:马来西亚银屑病的心理社会负担及其管理。
PLoS One. 2024 Jul 18;19(7):e0305870. doi: 10.1371/journal.pone.0305870. eCollection 2024.
4
Effects of tumor necrosis factor-alpha inhibitors on lipid profiles in patients with psoriasis: a systematic review and meta-analysis.肿瘤坏死因子-α抑制剂对银屑病患者血脂谱的影响:系统评价和荟萃分析。
Front Immunol. 2024 Mar 4;15:1354593. doi: 10.3389/fimmu.2024.1354593. eCollection 2024.
5
Deciphering the Mechanism of Xijiao Dihuang Decoction in Treating Psoriasis by Network Pharmacology and Experimental Validation.基于网络药理学和实验验证解析膝地黄汤治疗银屑病的作用机制。
Drug Des Devel Ther. 2023 Sep 12;17:2805-2819. doi: 10.2147/DDDT.S417954. eCollection 2023.

本文引用的文献

1
Hypertension Control and Guideline-Recommended Target Blood Pressure Goal Achievement at an Early Stage of Hypertension in the UAE.阿联酋高血压早期阶段的血压控制及指南推荐目标血压的达成情况
J Clin Med. 2021 Dec 23;11(1):47. doi: 10.3390/jcm11010047.
2
The Use of Metrics in Daily Practice and the Perception of Psoriasis-Associated Comorbidities: Discrepancies Between Research and Real-World.日常实践中指标的使用以及对银屑病相关合并症的认知:研究与现实世界之间的差异
Psoriasis (Auckl). 2021 Dec 21;11:169-175. doi: 10.2147/PTT.S341215. eCollection 2021.
3
Beyond the Skin Plaques: Psoriasis and Its Cardiovascular Comorbidities.皮肤斑块之外:银屑病及其心血管合并症
Cureus. 2021 Nov 17;13(11):e19679. doi: 10.7759/cureus.19679. eCollection 2021 Nov.
4
Non-Alcoholic Fatty Liver Disease (NAFLD) in Patients with Psoriasis: A Review of the Hepatic Effects of Systemic Therapies.银屑病患者的非酒精性脂肪性肝病(NAFLD):系统性治疗对肝脏影响的综述
Psoriasis (Auckl). 2021 Dec 7;11:151-168. doi: 10.2147/PTT.S342911. eCollection 2021.
5
The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease.与炎症性肠病相关的皮肤病患者中炎症性肠病延迟诊断的风险
Inflamm Bowel Dis. 2021 Oct 20;27(11):1731-1739. doi: 10.1093/ibd/izaa344.
6
Translating the 2019 AAD-NPF Guidelines of Care for Psoriasis With Attention to Comorbidities.关注共病问题,翻译 2019 年 AAD-NPF 银屑病治疗指南。
Cutis. 2021 Aug;108(2S):7-11. doi: 10.12788/cutis.0309.
7
Biologic Treatment in Combination with Lifestyle Intervention in Moderate to Severe Plaque Psoriasis and Concomitant Metabolic Syndrome: Rationale and Methodology of the METABOLyx Randomized Controlled Clinical Trial.生物制剂联合生活方式干预治疗中重度斑块状银屑病及合并代谢综合征:METABOLyx 随机对照临床试验的原理和方法。
Nutrients. 2021 Aug 29;13(9):3015. doi: 10.3390/nu13093015.
8
Psoriasis and Cardiometabolic Comorbidities: An Evaluation of the Impact of Systemic Treatments in Randomized Clinical Trials.银屑病与心血管代谢共病:随机临床试验中系统治疗影响的评估
Dermatol Ther (Heidelb). 2021 Oct;11(5):1497-1520. doi: 10.1007/s13555-021-00590-0. Epub 2021 Sep 10.
9
Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma.非酒精性脂肪性肝病与肝细胞癌的流行病学
JHEP Rep. 2021 May 11;3(4):100305. doi: 10.1016/j.jhepr.2021.100305. eCollection 2021 Aug.
10
Non-alcoholic fatty liver disease.非酒精性脂肪性肝病。
Lancet. 2021 Jun 5;397(10290):2212-2224. doi: 10.1016/S0140-6736(20)32511-3. Epub 2021 Apr 21.

银屑病与代谢综合征共病:临床意义及最佳管理

Comorbid Psoriasis and Metabolic Syndrome: Clinical Implications and Optimal Management.

作者信息

De Brandt Eveline, Hillary Tom

机构信息

Department of Dermatology, University Hospitals Leuven, Leuven, Belgium.

出版信息

Psoriasis (Auckl). 2022 May 25;12:113-126. doi: 10.2147/PTT.S293107. eCollection 2022.

DOI:10.2147/PTT.S293107
PMID:35651599
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9149586/
Abstract

PURPOSE

To review the literature on guidance on the follow-up of psoriasis and its comorbidities and to provide practical recommendations.

PATIENTS AND METHODS

A PubMed search was conducted using MeSH terms and free text keywords related to "psoriasis", "obesity", "hypertension", "diabetes", "dyslipidemia", "metabolic syndrome" and "Psoriatic arthritis". The search was conducted between September 2021 and January 2022. References of selected articles were scanned to identify additional articles.

RESULTS

Recommendations on the follow-up of hypertension, obesity, dyslipidemia, type 2 diabetes, metabolic syndrome, psoriatic arthritis, non-alcoholic fatty liver disease and inflammatory bowel disease in psoriasis patients were extracted from the included articles. These data are presented in summary tables for both adults and children. A practical and feasible approach for each comorbidity is discussed.

CONCLUSION

Awareness among dermatologists for relevant psoriasis-associated comorbidities is crucial. The dermatologist should function as gatekeeper and screen for comorbidities, in order to make timely referrals when indicated.

摘要

目的

回顾关于银屑病及其合并症随访指导的文献,并提供实用建议。

患者与方法

使用与“银屑病”“肥胖症”“高血压”“糖尿病”“血脂异常”“代谢综合征”及“银屑病关节炎”相关的医学主题词(MeSH)和自由文本关键词在PubMed上进行检索。检索于2021年9月至2022年1月进行。对所选文章的参考文献进行筛选以识别其他文章。

结果

从纳入的文章中提取了关于银屑病患者高血压、肥胖症、血脂异常、2型糖尿病、代谢综合征、银屑病关节炎、非酒精性脂肪性肝病和炎症性肠病随访的建议。这些数据以成人和儿童的汇总表形式呈现。讨论了针对每种合并症的实用可行方法。

结论

皮肤科医生对相关银屑病合并症的认识至关重要。皮肤科医生应充当守门人并筛查合并症,以便在需要时及时进行转诊。